A Topic Working Group comprised of individuals with relevant expertise in the management of heavy menstrual bleeding, and experience in the Australian health care system as well as representatives of major consumer organisations, has been convened to provide clinical advice, expertise and consumer input to this work.
All members are required to disclose financial, personal and professional interests that could, or could be perceived to, influence a decision made, or advice given to the Commission. Disclosures are updated prior to each meeting and managed in line with the Commission’s Policy on Disclosure of Interests.
The Heavy Menstrual Bleeding Clinical Care Standard aims to ensure that women with heavy menstrual bleeding are offered the least invasive and most effective treatment appropriate to their clinical needs, and have the opportunity to make an informed choice from the range of treatments suitable to their individual situation.
The Heavy Menstrual Bleeding Clinical Care Standard provides advice to clinicians, consumers and health services on key components of care including:
The Commission undertook a public consultation on the draft Heavy Menstrual Bleeding Clinical Care Standard and related documentation from 23 November 2016 to 11 January 2017. Submissions were received from a range of stakeholders including individuals, professional and peak organisations, hospitals and other health services.
The Commission will be working with stakeholders over the coming months to identify strategies to implement the Heavy Menstrual Bleeding Clinical Care Standard. This includes exploring the barriers and enablers to implementation, and identifying changes that need to occur in clinical practice and in health services for care to be routinely provided in a way that is consistent with the clinical care standard.